Shreis Scalene Therapeutics

Shreis Scalene Therapeutics is a private U.S.-based health-tech and medical device company within the Shreis Scalene Group focused on non-invasive therapeutic and diagnostic technologies. Its portfolio centers on device-based platforms including Cytotron for regenerative medicine and oncology applications, CELLFORN/FORN for targeted drug delivery, and SHYCOCAN for attenuation or disabling of certain airborne viruses including coronaviruses. The company positions itself at the intersection of therapeutic devices, drug-delivery enhancement, and diagnostic innovation rather than traditional drug development. Publicly available information suggests the business remains private and active, with commercialization and regulatory efforts focused mainly on the Americas and selected international markets. Its pipeline appears to be predominantly device-based and early-stage, with limited evidence of conventional clinical-stage biopharmaceutical assets.